首页 > 市场调查报告书 > 製药

生物保存市场规模、份额和成长分析（按产品、生物样本、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898440

生物保存市场规模、份额和成长分析（按产品、生物样本、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Biopreservation Market Size, Share, and Growth Analysis, By Product (Biopreservation Media, Biopreservation Equipment), By Biospecimen (Human Tissue Samples, Organs), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球生物保存市场规模预计在 2024 年达到 35.9 亿美元，从 2025 年的 46.1 亿美元成长到 2033 年的 338.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 28.3%。

全球生物保存市场正经历强劲成长，这主要得益于技术创新不断改进生物材料（如DNA、组织和干细胞）在不同条件下的保存方法。近期的一些创新，例如微阵列和预测建模的整合，简化了生物保存流程，降低了时间和成本。多重细胞成像平台的兴起进一步提升了生物保存的效能。该技术的应用范围正在不断扩大，涵盖心臟病学和妇科等领域。慢性病的快速成长推动了生技药品研发领域的需求，包括免疫疗法和疫苗生产。此外，公私合作也促进了研究经费的增加。医疗保健成本的上升预计将推动人们对干细胞保存和生物来源日益增长的兴趣，进而推动市场成长。

全球生物防腐市场驱动因素

全球慢性病发生率的上升趋势正显着推动全球生物製品保存市场的需求。在美国等已开发国家，超过30%的成年人患有慢性病，而在印度等开发中国家，这一比例也超过23%。慢性病的持续成长迫切需要有效的诊断和替代治疗方案，从而增加了对生物製品保存策略的需求。医疗保健技术的进步以及生物製品保存在确保治疗应用安全性和有效性以及维持生物製品活性方面的重要作用，进一步推动了这项需求的成长。因此，预计该市场将持续成长。

全球生物保存市场面临的限制因素

全球生物保存市场面临诸多限制因素，阻碍了其成长潜力。有效的生物保存依赖于对温度、压力、pH值以及其他物理因素的精确控制，这些因素需根据待保存生物质的特定稳定性进行调整。这需要先进的设备、专用耗材和培养基，而所有这些都需要熟练的人员才能有效操作。此外，许多耗材极不稳定或供应有限，进一步增加了生物保存过程的复杂性。建立必要基础设施的高昂初始投资成本限制了生物保存技术在各个领域的广泛应用，最终阻碍了市场扩张。

全球生物防腐市场趋势

全球生物保存市场呈现强劲的上升趋势，预计将以显着的复合年增长率成长，这主要得益于细胞疗法和基因工程需求的激增。这种成长促使生物医药公司加大研发投入。细胞和基因疗法在诊断和治疗严重病人及慢性疾病方面的巨大潜力正日益受到广泛认可。此外，政府对基因疗法和再生医学研究中心的资助不断增加，进一步推动了市场发展，凸显了生物保存在现代医疗保健发展中日益增长的重要性。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- 赛默飞世尔科技公司（美国）
- 默克集团（德国）
- BioLife Solutions, Inc.（美国）
- 干细胞技术（加拿大）
- Helmer Scientific Inc.（美国）
- 普林斯顿低温治疗中心（美国）
- OPS Diagnostics（美国）
- ThermoGenesis Holdings, Inc.（美国）
- Avantor公司（美国）
- Bio-Techne公司（美国）
- 精确科学公司（美国）
- 沃辛顿工业公司（美国）
- Chart Industries, Inc.（美国）
- Azenta US, Inc.（美国）
- LabVantage Solutions, Inc.（美国）
- Qiagen NV（荷兰）
- Taylor-Wharton Cryogenics LLC（美国）
- PHC控股株式会社（日本）
- 松下电器产业株式会社（日本）
- Lifeline Scientific, Inc.（美国）

结论与建议

简介目录

Product Code: SQMIG35I2223

Global Biopreservation Market size was valued at USD 3.59 Billion in 2024 and is poised to grow from USD 4.61 Billion in 2025 to USD 33.82 Billion by 2033, growing at a CAGR of 28.3% during the forecast period (2026-2033).

The Global Biopreservation Market is witnessing robust growth driven by technological advancements that enhance the preservation of biological materials, including DNA, tissues, and stem cells, under varied conditions. Recent innovations, such as microarrays and predictive modeling integration, have streamlined biopreservation processes, reducing time and costs. The rise of multiplex cellular imaging platforms further boosts biopreservation efficacy. This approach finds increased applications in specialties like cardiology and gynecology. The surging prevalence of chronic diseases fuels the demand for biological products, spanning immunotherapies and vaccine production, in R&D sectors. Additionally, collaboration between public and private entities is enhancing research funding. Growing interest in stem cell preservation and biologically derived medicines is poised to propel market growth, supported by rising healthcare expenditures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segments Analysis

Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region. Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories. Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens. Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications. Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopreservation Market

The increasing prevalence of chronic diseases worldwide significantly drives the demand for the global biopreservation market. In advanced economies like the United States, over 30% of adults are affected by such conditions, while developing nations, such as India, report figures exceeding 23%. The persistent rise in chronic diseases necessitates effective diagnosis and alternative treatment solutions, thereby amplifying the need for biopreservation strategies. This growing demand is further fueled by advancements in healthcare technologies and the crucial role biopreservation plays in maintaining the viability of biological products, ensuring their safety and efficacy in therapeutic applications. As such, the market is poised for continuous growth.

Restraints in the Global Biopreservation Market

The Global Biopreservation market faces several constraints that hinder its growth potential. Effective biopreservation relies on precise control of temperature, pressure, pH, and other physical factors tailored to the specific stability of the biomass being preserved. This necessitates sophisticated equipment, specialized consumables, and media solutions, all of which require skilled personnel to operate effectively. Additionally, many of these consumables are either highly unstable or have limited availability, further complicating the biopreservation process. The substantial initial investment costs associated with setting up the necessary infrastructure restrict the broader application of biopreservation techniques across various sectors, ultimately limiting market expansion.

Market Trends of the Global Biopreservation Market

The Global Biopreservation market is experiencing a robust upward trajectory, fueled by the surging demand for cell therapy and genetic engineering, with projections indicating a remarkable compound annual growth rate. This growth is prompting significant investments from biomedical companies aimed at advancing research and development initiatives. The transformative potential of cell and gene therapies in diagnosing and treating critical patients and chronic diseases is gaining widespread recognition. Additionally, increased government funding directed towards research centers specializing in gene therapy and regenerative treatments is further propelling the market forward, highlighting the escalating importance of biopreservation in modern healthcare advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis

Global Biopreservation Market Size by Product & CAGR (2026-2033)

Market Overview
Biopreservation Media
- Cryopreservation Media
- Hypothermic Preservation Media
Biopreservation Equipment
- Temperature Control Systems
- Freezers
- Cryogenic Storage Systems
- Thawing Equipment
- Refrigerators
- Alarm Monitoring Systems
- Incubators
- Centrifuges
- Other Biopreservation Equipment
Biopreservation Accessories

Global Biopreservation Market Size by Biospecimen & CAGR (2026-2033)

Market Overview
Human Tissue Samples
Organs
Stem Cells
Other Biospecimens

Global Biopreservation Market Size by Application & CAGR (2026-2033)

Market Overview
Research Applications
Therapeutic Applications
Other Applications

Global Biopreservation Market Size by End User & CAGR (2026-2033)

Market Overview
Biobanks
Gene Banks
Hospitals
Other End Users

Global Biopreservation Market Size & CAGR (2026-2033)

North America (Product, Biospecimen, Application, End User)
- US
- Canada
Europe (Product, Biospecimen, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Biospecimen, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Biospecimen, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Biospecimen, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helmer Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PrincetonCryo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPS Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThermoGenesis Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worthington Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta US, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabVantage Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taylor-Wharton Cryogenics LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panasonic Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeline Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments